• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Insiders Buying Monro And 3 Other Stocks

    2/9/24 8:35:25 AM ET
    $KALV
    $LEE
    $MNRO
    $POST
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Newspapers/Magazines
    Consumer Discretionary
    Get the next $KALV alert in real time by email

    Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

    When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

    Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.

    KalVista Pharmaceuticals

    • The Trade: KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) 10% owner Nimish P Shah acquired a total of 86,048 shares an average price of $14.62. To acquire these shares, it cost around $1,257,829.
    • What’s Happening: KalVista Pharma, during December, announced publication of first oral factor XIIa data in Frontiers in Pharmacology.
    • What KalVista Pharmaceuticals Does: KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases.

    Post Holdings

    • The Trade: Post Holdings, Inc. (NYSE:POST) Director Thomas C ERB acquired a total of 1,000 shares at an average price of $104.24. To acquire these shares, it cost around $104,240.
    • What’s Happening: Post Holdings reported better-than-expected first-quarter results.
    • What Post Holdings Does: Post Holdings Inc is an consumer packaged goods holding company.

    Don’t forget to check out our premarket coverage here

    Lee Enterprises

    • The Trade: Lee Enterprises, Incorporated (NASDAQ:LEE) Director Steven C. Fletcher bought a total of 2,000 shares at an average price of $9.99. To acquire these shares, it cost around $19,976.
    • What’s Happening: Lee Enterprises posted a profit for the first quarter.
    • What Lee Enterprises Does: Lee Enterprises Inc is a local news publication company in the United States.

    Monro

    • The Trade: Monro, Inc. (NASDAQ:MNRO) CEO and President Michael T Broderick bought a total of 5,000 shares at an average price of $32.30. The insider spent around $161,490 to buy those shares.
    • What’s Happening: Monro posted in-line earnings for its third quarter.
    • What Monro Does: Monro Inc is a provider automobile service stations in the United States.

     

    Check This Out: Pinterest, PepsiCo And 3 Stocks To Watch Heading Into Friday

    Get the next $KALV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KALV
    $LEE
    $MNRO
    $POST

    CompanyDatePrice TargetRatingAnalyst
    Monro Inc.
    $MNRO
    2/11/2026$40.00Perform → Outperform
    Oppenheimer
    KalVista Pharmaceuticals Inc.
    $KALV
    1/9/2026$32.00 → $35.00Buy
    Needham
    KalVista Pharmaceuticals Inc.
    $KALV
    1/6/2026$28.00 → $32.00Buy
    Needham
    Post Holdings Inc.
    $POST
    8/20/2025$122.00Overweight
    Analyst
    Monro Inc.
    $MNRO
    4/4/2025$18.00Equal-Weight → Overweight
    Stephens
    KalVista Pharmaceuticals Inc.
    $KALV
    1/31/2025$19.00Mkt Outperform
    JMP Securities
    KalVista Pharmaceuticals Inc.
    $KALV
    1/7/2025$30.00Buy
    TD Cowen
    Monro Inc.
    $MNRO
    12/19/2024$31.00Outperform
    Wedbush
    More analyst ratings

    $KALV
    $LEE
    $MNRO
    $POST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Quint Digital Ltd bought $7,966,874 worth of shares (2,451,346 units at $3.25), increasing direct ownership by 321% to 3,214,346 units (SEC Form 4)

    4 - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/11/26 6:08:54 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    President and CEO Fitzsimmons Peter D bought $250,879 worth of shares (12,750 units at $19.68), increasing direct ownership by 13% to 112,033 units (SEC Form 4)

    4 - MONRO, INC. (0000876427) (Issuer)

    2/9/26 3:51:15 PM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    President and CEO Fitzsimmons Peter D bought $251,017 worth of shares (13,350 units at $18.80), increasing direct ownership by 16% to 99,283 units (SEC Form 4)

    4 - MONRO, INC. (0000876427) (Issuer)

    2/5/26 3:32:45 PM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    $KALV
    $LEE
    $MNRO
    $POST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Monro Muffler upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Monro Muffler from Perform to Outperform and set a new price target of $40.00

    2/11/26 7:42:13 AM ET
    $MNRO
    Automotive Aftermarket
    Consumer Discretionary

    Needham reiterated coverage on KalVista Pharmaceuticals with a new price target

    Needham reiterated coverage of KalVista Pharmaceuticals with a rating of Buy and set a new price target of $35.00 from $32.00 previously

    1/9/26 7:49:25 AM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Needham reiterated coverage on KalVista Pharmaceuticals with a new price target

    Needham reiterated coverage of KalVista Pharmaceuticals with a rating of Buy and set a new price target of $32.00 from $28.00 previously

    1/6/26 7:58:35 AM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $KALV
    $LEE
    $MNRO
    $POST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Quint Digital Ltd bought $7,966,874 worth of shares (2,451,346 units at $3.25), increasing direct ownership by 321% to 3,214,346 units (SEC Form 4)

    4 - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/11/26 6:08:54 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Director Curl Gregory L sold $798,221 worth of shares (6,983 units at $114.31), decreasing direct ownership by 25% to 21,293 units (SEC Form 4)

    4 - Post Holdings, Inc. (0001530950) (Issuer)

    2/10/26 5:01:34 PM ET
    $POST
    Packaged Foods
    Consumer Staples

    President & CEO Mowbray Kevin covered exercise/tax liability with 7,867 shares, decreasing direct ownership by 6% to 118,970 units (SEC Form 4)

    4 - LEE ENTERPRISES, Inc (0000058361) (Issuer)

    2/9/26 3:53:07 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    $KALV
    $LEE
    $MNRO
    $POST
    SEC Filings

    View All

    SEC Form 10-Q filed by Lee Enterprises Incorporated

    10-Q - LEE ENTERPRISES, Inc (0000058361) (Filer)

    2/11/26 9:01:35 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Lee Enterprises Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LEE ENTERPRISES, Inc (0000058361) (Filer)

    2/10/26 11:10:55 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    SEC Form 144 filed by Post Holdings Inc.

    144 - Post Holdings, Inc. (0001530950) (Subject)

    2/9/26 7:07:32 PM ET
    $POST
    Packaged Foods
    Consumer Staples

    $KALV
    $LEE
    $MNRO
    $POST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KalVista Pharmaceuticals to Present EKTERLY® (sebetralstat) Data at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting

    KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) today announced the acceptance of three abstracts for presentation at the 2026 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting taking place in Philadelphia, Pennsylvania from February 27–March 2, 2026. The following poster presentations will take place on Friday, February 27 from 2:45–3:45 pm ET in the Convention Center, Level 2, Hall E: Response Drivers in Sebetralstat Placebo-controlled Clinical Trials: Jonathan Bernstein, Emel Aygören-Pürsün, Danny Cohn, Henriette Farkas, William Lumry, Andrea Zanichelli, James Hao, Matthew Iverson, Michael Smith, Paul Audhya, Erik Hansen, Nathan Teuscher, Marc Riedl. On-demand

    2/12/26 7:00:00 AM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lee Enterprises Reports Strong First Quarter Results and Closing of Strategic Investment

    Q1 Adjusted EBITDA(1) growth of $5M or 61% YOY$50M equity investment(2) enhances financial stabilityInterest rate on outstanding debt reduced to 5% from 9%(3) DAVENPORT, Iowa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ:LEE), a digital-first subscription platform providing high quality, trusted, local news, information and a major platform for advertising in 72 markets, today reported preliminary first quarter fiscal 2026 financial results(4) for the period ended December 28, 2025. "Our core business delivered operating results in the first quarter that exceeded our expectations," said Nathan Bekke, Lee's President and Interim Chief Executive Officer.

    2/10/26 7:00:00 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Lee Enterprises and Hudl Partner to Expand Access to High School Sports, Connecting Fans, Athletes, and Coaches to Local Communities at Scale

    DAVENPORT, Iowa, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Lee Enterprises and Hudl today announced a new content partnership that significantly expands access to high school sports coverage across Lee's nationwide network of trusted local news brands, marking one of the largest collaborations in local sports media. Through this partnership, the two companies will work to bring high-quality high school sports video and storytelling across Lee Enterprises' 72 markets, reaching millions of local sports fans, families, coaches, and student athletes. Together, Lee and Hudl will connect communities to the moments, teams, and athletes that matter most — at a scale unmatched in local sports coverage.

    2/9/26 10:05:23 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    $KALV
    $LEE
    $MNRO
    $POST
    Financials

    Live finance-specific insights

    View All

    Lee Enterprises Reports Strong First Quarter Results and Closing of Strategic Investment

    Q1 Adjusted EBITDA(1) growth of $5M or 61% YOY$50M equity investment(2) enhances financial stabilityInterest rate on outstanding debt reduced to 5% from 9%(3) DAVENPORT, Iowa, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ:LEE), a digital-first subscription platform providing high quality, trusted, local news, information and a major platform for advertising in 72 markets, today reported preliminary first quarter fiscal 2026 financial results(4) for the period ended December 28, 2025. "Our core business delivered operating results in the first quarter that exceeded our expectations," said Nathan Bekke, Lee's President and Interim Chief Executive Officer.

    2/10/26 7:00:00 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Post Holdings Reports Results for the First Quarter of Fiscal Year 2026; Raises Fiscal Year 2026 Outlook

    ST. LOUIS, Feb. 5, 2026 /PRNewswire/ -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the first fiscal quarter ended December 31, 2025. Highlights: First quarter net sales of $2.2 billion Operating profit of $238.4 million; net earnings of $96.8 million and Adjusted EBITDA (non-GAAP)* of $418.2 millionRaised fiscal year 2026 Adjusted EBITDA (non-GAAP)* outlook to $1,550-$1,580 million*For additional information regarding non-GAAP measures, such as Adjusted EBITDA, Adjusted net earnings, Adjusted diluted earnings per comm

    2/5/26 5:00:00 PM ET
    $POST
    Packaged Foods
    Consumer Staples

    Lee Enterprises plans quarterly call and webcast February 10, 2026

    DAVENPORT, Iowa, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ:LEE), a major subscription and advertising platform and a leading provider of high quality, trusted, local news and information in 72 markets, has scheduled an audio webcast and conference call for Tuesday, February 10, 2026, at 9 a.m. Central Time. Lee plans to issue a news release before the market opens that day with preliminary results for its quarter ended December 28, 2025. A live webcast of the conference call may be accessed via the Investor Relations portion of Lee's website or here. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in nu

    1/29/26 11:00:00 AM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    $KALV
    $LEE
    $MNRO
    $POST
    Leadership Updates

    Live Leadership Updates

    View All

    Greg Pearson to Join Post Consumer Brands as President and Chief Executive Officer

    ST. LOUIS, Feb. 5, 2026 /PRNewswire/ -- Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today announced Greg Pearson will join the company as President and Chief Executive Officer of Post Consumer Brands, effective April 1, 2026. Pearson will succeed Nicolas Catoggio, who assumed the role of Post Holdings EVP, Chief Operating Officer in January 2026. Pearson joins Post from Compana Pet Brands, a global leader in pet care and nutrition based in St. Louis, where he has served as Chief Executive Officer since January 2023. With Compana, Pearson has led

    2/5/26 8:30:00 AM ET
    $POST
    Packaged Foods
    Consumer Staples

    Lee Enterprises, Inc. Announces Resignation of Chief Financial Officer Tim Millage

    DAVENPORT, Iowa, Nov. 21, 2025 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ:LEE) today announced Chief Financial Officer, Tim Millage, will depart the company early next year to answer a calling outside of corporate life. After nearly a decade of leading financial organizations in public companies, he will become an Executive Pastor at Coram Deo Bible Church in Davenport, Iowa. "Serving Lee has been one of the greatest privileges of my professional life. I'm leaving to put my full time and full heart into serving the church," said Millage. "I have tremendous respect for Kevin and the leadership team, and I have full confidence in the company's direction and its bright future.

    11/21/25 5:32:08 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    KalVista Pharmaceuticals Appoints Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer

    KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) today announced the appointments of Bilal Arif as Chief Operating Officer and Linea Aspesi as Chief People Officer, effective October 6, 2025. "I am pleased to welcome Bilal and Linea to our leadership team as we advance the global launch of EKTERLY," said Ben Palleiko, Chief Executive Officer of KalVista. "Their respective expertise in operations and human resources will be instrumental as we deliver on our commitment to people living with HAE." "I am excited to join KalVista and collaborate with such a talented team," said Mr. Arif. "This is a pivotal time for EKTERLY, and I am focused on strengthening the operational framework to ensure pe

    10/6/25 7:00:00 AM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $KALV
    $LEE
    $MNRO
    $POST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lee Enterprises Incorporated

    SC 13D/A - LEE ENTERPRISES, Inc (0000058361) (Subject)

    11/14/24 4:18:56 PM ET
    $LEE
    Newspapers/Magazines
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by KalVista Pharmaceuticals Inc.

    SC 13G/A - KalVista Pharmaceuticals, Inc. (0001348911) (Subject)

    11/14/24 4:00:06 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by KalVista Pharmaceuticals Inc.

    SC 13G/A - KalVista Pharmaceuticals, Inc. (0001348911) (Subject)

    11/14/24 3:57:49 PM ET
    $KALV
    Biotechnology: Pharmaceutical Preparations
    Health Care